Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2015

Open Access 01-12-2015 | Research

Breast cancer survival experiences at a tertiary hospital in sub-Saharan Africa: a cohort study

Authors: Moses Galukande, Henry Wabinga, Florence Mirembe

Published in: World Journal of Surgical Oncology | Issue 1/2015

Login to get access

Abstract

Background

Cancer of the breast is a major health burden and the most common cancer among women worldwide. Though its incidence is fourfold greater in high-income countries, in sharp contrast, mortality rates are greatest among the low-income countries. Early detection linked to appropriate treatment is the most effective strategy to improve survival. The purpose of this study therefore was to establish the survival experiences of women with breast cancer at a Ugandan hospital.

Methods

This study is an observational analytical study. It involved 262 women during the periods 2004 to 2007 and 2010 to 2012. Kaplan Meier method and Cox regression were used to calculate breast cancer mortality and cumulative survival experiences.

Results

Sixty-three out of 262 (23 %) deaths were observed; mean age was 45 years, and 91 observations ended on or before follow-up. Luminal B median survival was months. The 5-year cumulative survival was 51.8 %. There were no stage I and II deaths. There were no differences in survival by phenotype adjusted for age, but there were differences for stage IV (p = 0.05).

Conclusions

The cumulative 5-year survival was 51.8 %. The burden of advanced disease and associated mortality were high, and a significant number of patients were lost to follow-up after their first contact.
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.PubMedCrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.PubMedCrossRef
3.
go back to reference Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. Pan Afr Med J. 2014;17:249.PubMedCentralPubMed Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. Pan Afr Med J. 2014;17:249.PubMedCentralPubMed
4.
go back to reference Gakwaya A, Galukande M, Luwaga A, Jombwe J, Fualal J, Kiguli-Malwadde E, et al. Breast cancer guidelines for Uganda (2nd edition 2008). Afr Health Sci. 2008;8(2):126–33.PubMedCentralPubMed Gakwaya A, Galukande M, Luwaga A, Jombwe J, Fualal J, Kiguli-Malwadde E, et al. Breast cancer guidelines for Uganda (2nd edition 2008). Afr Health Sci. 2008;8(2):126–33.PubMedCentralPubMed
5.
go back to reference Sseggwanyi J, Galukande M, Fualal J, Jombwe J. Prevalence of HIV/AIDS among breast cancer patients and the associated clinico-pathological features. Ann Afr Surg. 2011;8:22–7. Sseggwanyi J, Galukande M, Fualal J, Jombwe J. Prevalence of HIV/AIDS among breast cancer patients and the associated clinico-pathological features. Ann Afr Surg. 2011;8:22–7.
6.
go back to reference Nalwoga H, Arnes JB, Wabinga H, Akslen LA. Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women. AMPIS. 2008;116(6):515–25. Nalwoga H, Arnes JB, Wabinga H, Akslen LA. Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women. AMPIS. 2008;116(6):515–25.
7.
go back to reference Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol. 2009;27:4515–21.PubMedCentralPubMedCrossRef Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol. 2009;27:4515–21.PubMedCentralPubMedCrossRef
8.
go back to reference Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol. 2008;15:1983–8.PubMedCrossRef Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol. 2008;15:1983–8.PubMedCrossRef
9.
go back to reference Coleman PM, Quaresma M, Berrino F, Lutz JM, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730–56.PubMedCrossRef Coleman PM, Quaresma M, Berrino F, Lutz JM, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730–56.PubMedCrossRef
10.
go back to reference Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113(8):2221–43.PubMedCrossRef Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113(8):2221–43.PubMedCrossRef
11.
go back to reference Galukande M, Kiguli ME. Rethinking breast cancer screening strategies in resource-limited environments. Afr Health Sci J. 2010;10(1):89–92. Galukande M, Kiguli ME. Rethinking breast cancer screening strategies in resource-limited environments. Afr Health Sci J. 2010;10(1):89–92.
12.
go back to reference Reiner A, Neumeister B, Spora J, et al. Immunocytochemical localization of oestrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res. 2000;50:7057–61. Reiner A, Neumeister B, Spora J, et al. Immunocytochemical localization of oestrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res. 2000;50:7057–61.
13.
go back to reference Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, the value of histological grade in breast cancer experience from a large study with long term follow up. Histopathology. 1991;19:401–10.CrossRef Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, the value of histological grade in breast cancer experience from a large study with long term follow up. Histopathology. 1991;19:401–10.CrossRef
14.
go back to reference Sledge GW, Mamounas EP, Hortobagyi GN, Burstein HJ, Goodwin PJ, Wolff AC. Past, present, and future challenges in breast cancer treatment. J Clin Oncol. 2014;32(19):1979–86.PubMedCrossRef Sledge GW, Mamounas EP, Hortobagyi GN, Burstein HJ, Goodwin PJ, Wolff AC. Past, present, and future challenges in breast cancer treatment. J Clin Oncol. 2014;32(19):1979–86.PubMedCrossRef
15.
go back to reference Tejal AP, Bhuvanesh D, Rodriguez AA, Chang J, Perez EA, Colon-Otero G. Dual HER2 blockade: preclinical and Clinical data. Breast Cancer Res. 2014;16:419.CrossRef Tejal AP, Bhuvanesh D, Rodriguez AA, Chang J, Perez EA, Colon-Otero G. Dual HER2 blockade: preclinical and Clinical data. Breast Cancer Res. 2014;16:419.CrossRef
16.
go back to reference Criscitiello C, Esposito A, Gelao L, Fumagali L, Locatelli M, Minchella I, et al. Immune approaches to the treatment of breast cancer around the corner? Breast Cancer Res. 2014;16:204.PubMedCentralPubMedCrossRef Criscitiello C, Esposito A, Gelao L, Fumagali L, Locatelli M, Minchella I, et al. Immune approaches to the treatment of breast cancer around the corner? Breast Cancer Res. 2014;16:204.PubMedCentralPubMedCrossRef
17.
go back to reference Sighoko D, Bah E, Haukka J, et al. Population based breast (Female) and cervix rates in the Gambia: evidence of ethnicity –related variations. Int J Cancer. 2010;127:2248–56.PubMedCrossRef Sighoko D, Bah E, Haukka J, et al. Population based breast (Female) and cervix rates in the Gambia: evidence of ethnicity –related variations. Int J Cancer. 2010;127:2248–56.PubMedCrossRef
18.
19.
go back to reference Lingwood RJ, Boyle P, Milburn A, Arbuthnott J, Ngoma T, McCaffrey R, et al. The challenge of cancer control in Africa. Nat Rev Cancer. 2008;398–403. Lingwood RJ, Boyle P, Milburn A, Arbuthnott J, Ngoma T, McCaffrey R, et al. The challenge of cancer control in Africa. Nat Rev Cancer. 2008;398–403.
20.
go back to reference Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African. Lancet. 1997;349(9061):1269–76.CrossRef Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African. Lancet. 1997;349(9061):1269–76.CrossRef
21.
go back to reference Adesina A, Chumba D, Nelson AM, Orem J, Roberts DJ, Wabinga H, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 2013;14(4):e152–7.PubMedCrossRef Adesina A, Chumba D, Nelson AM, Orem J, Roberts DJ, Wabinga H, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 2013;14(4):e152–7.PubMedCrossRef
Metadata
Title
Breast cancer survival experiences at a tertiary hospital in sub-Saharan Africa: a cohort study
Authors
Moses Galukande
Henry Wabinga
Florence Mirembe
Publication date
01-12-2015
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2015
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-015-0632-4

Other articles of this Issue 1/2015

World Journal of Surgical Oncology 1/2015 Go to the issue